| Salivary Gland Disorders and Functions | Lifetime | 1 | FR 1 | 99.89 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 19 | FR 1 | 99.67 |
| Systemic Lupus Erythematosus Research | Lifetime | 42 | FR 2 | 99.73 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 169 | FR 9 | 99.48 |
| Diabetes and associated disorders | Lifetime | 128 | FR 4 | 99.23 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 94 | FR 6 | 99.54 |
| Long-Term Effects of COVID-19 | Lifetime | 156 | FR 10 | 98.41 |
| Lymphoma Diagnosis and Treatment | Lifetime | 409 | FR 26 | 98.91 |
| COVID-19 Clinical Research Studies | Lifetime | 524 | FR 30 | 98.00 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 172 | FR 12 | 98.79 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 998 | FR 35 | 98.48 |
| Infectious Diseases and Tuberculosis | Lifetime | 427 | FR 18 | 96.68 |
| Systemic Sclerosis and Related Diseases | Lifetime | 431 | FR 35 | 96.91 |
| Multiple Myeloma Research and Treatments | Lifetime | 924 | FR 59 | 95.74 |
| Peripheral Neuropathies and Disorders | Lifetime | 708 | FR 48 | 95.13 |
| Oral Health Pathology and Treatment | Lifetime | 842 | FR 15 | 93.44 |
| Pregnancy and Medication Impact | Lifetime | 898 | FR 32 | 92.47 |
| Chemokine receptors and signaling | Lifetime | 952 | FR 24 | 89.60 |
| Lymphatic System and Diseases | Lifetime | 694 | FR 9 | 89.06 |
| Dermatological and COVID-19 studies | Lifetime | 940 | FR 55 | 72.44 |
| Salivary Gland Disorders and Functions | 2021-2025 | 1 | FR 1 | 99.67 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 5 | FR 1 | 99.25 |
| Long-Term Effects of COVID-19 | 2021-2025 | 116 | FR 6 | 98.54 |
| COVID-19 Clinical Research Studies | 2021-2025 | 356 | FR 17 | 98.27 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 177 | FR 10 | 97.21 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 183 | FR 9 | 97.06 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 352 | FR 17 | 96.33 |
| Diabetes and associated disorders | 2021-2025 | 547 | FR 11 | 90.24 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 276 | FR 13 | 87.78 |
| Dermatological and COVID-19 studies | 2021-2025 | 113 | FR 2 | 81.12 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 709 | FR 40 | 84.13 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 615 | FR 11 | 83.22 |
| Chemokine receptors and signaling | 2021-2025 | 459 | FR 15 | 64.07 |
